vs

Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and Madison Square Garden Sports Corp. (MSGS). Click either name above to swap in a different company.

Madison Square Garden Sports Corp. is the larger business by last-quarter revenue ($403.4M vs $208.9M, roughly 1.9× iRhythm Holdings, Inc.). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs 2.0%, a 0.6% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 12.8%). Madison Square Garden Sports Corp. produced more free cash flow last quarter ($31.6M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs -3.1%).

iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.

Madison Square Garden Sports Corp. is an American sports holding company based in New York City.

IRTC vs MSGS — Head-to-Head

Bigger by revenue
MSGS
MSGS
1.9× larger
MSGS
$403.4M
$208.9M
IRTC
Growing faster (revenue YoY)
IRTC
IRTC
+14.4% gap
IRTC
27.1%
12.8%
MSGS
Higher net margin
IRTC
IRTC
0.6% more per $
IRTC
2.7%
2.0%
MSGS
More free cash flow
MSGS
MSGS
$17.1M more FCF
MSGS
$31.6M
$14.5M
IRTC
Faster 2-yr revenue CAGR
IRTC
IRTC
Annualised
IRTC
25.8%
-3.1%
MSGS

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
IRTC
IRTC
MSGS
MSGS
Revenue
$208.9M
$403.4M
Net Profit
$5.6M
$8.2M
Gross Margin
70.9%
Operating Margin
1.1%
5.5%
Net Margin
2.7%
2.0%
Revenue YoY
27.1%
12.8%
Net Profit YoY
518.5%
641.9%
EPS (diluted)
$0.18
$0.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRTC
IRTC
MSGS
MSGS
Q4 25
$208.9M
$403.4M
Q3 25
$192.9M
$39.5M
Q2 25
$186.7M
$204.0M
Q1 25
$158.7M
$424.2M
Q4 24
$164.3M
$357.8M
Q3 24
$147.5M
$53.3M
Q2 24
$148.0M
$227.3M
Q1 24
$131.9M
$430.0M
Net Profit
IRTC
IRTC
MSGS
MSGS
Q4 25
$5.6M
$8.2M
Q3 25
$-5.2M
$-8.8M
Q2 25
$-14.2M
$-1.8M
Q1 25
$-30.7M
$-14.2M
Q4 24
$-1.3M
$1.1M
Q3 24
$-46.2M
$-7.5M
Q2 24
$-20.1M
$25.5M
Q1 24
$-45.7M
$37.9M
Gross Margin
IRTC
IRTC
MSGS
MSGS
Q4 25
70.9%
Q3 25
71.1%
Q2 25
71.2%
Q1 25
68.8%
Q4 24
70.0%
Q3 24
68.8%
Q2 24
69.9%
Q1 24
66.3%
Operating Margin
IRTC
IRTC
MSGS
MSGS
Q4 25
1.1%
5.5%
Q3 25
-4.4%
-69.5%
Q2 25
-10.0%
-11.1%
Q1 25
-20.5%
7.6%
Q4 24
-2.5%
3.7%
Q3 24
-34.1%
-15.5%
Q2 24
-15.5%
23.0%
Q1 24
-28.9%
18.5%
Net Margin
IRTC
IRTC
MSGS
MSGS
Q4 25
2.7%
2.0%
Q3 25
-2.7%
-22.3%
Q2 25
-7.6%
-0.9%
Q1 25
-19.3%
-3.4%
Q4 24
-0.8%
0.3%
Q3 24
-31.3%
-14.1%
Q2 24
-13.6%
11.2%
Q1 24
-34.6%
8.8%
EPS (diluted)
IRTC
IRTC
MSGS
MSGS
Q4 25
$0.18
$0.34
Q3 25
$-0.16
$-0.37
Q2 25
$-0.44
$-0.08
Q1 25
$-0.97
$-0.59
Q4 24
$-0.03
$0.05
Q3 24
$-1.48
$-0.31
Q2 24
$-0.65
$1.07
Q1 24
$-1.47
$1.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRTC
IRTC
MSGS
MSGS
Cash + ST InvestmentsLiquidity on hand
$583.8M
$81.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$152.7M
$-282.1M
Total Assets
$1.0B
$1.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRTC
IRTC
MSGS
MSGS
Q4 25
$583.8M
$81.3M
Q3 25
$565.2M
$48.6M
Q2 25
$545.5M
$144.6M
Q1 25
$520.6M
$96.5M
Q4 24
$535.6M
$107.8M
Q3 24
$522.0M
$52.3M
Q2 24
$561.5M
$89.1M
Q1 24
$569.1M
$40.0M
Stockholders' Equity
IRTC
IRTC
MSGS
MSGS
Q4 25
$152.7M
$-282.1M
Q3 25
$121.9M
$-294.2M
Q2 25
$103.7M
$-281.4M
Q1 25
$86.7M
$-283.4M
Q4 24
$90.9M
$-273.1M
Q3 24
$71.8M
$-277.5M
Q2 24
$99.2M
$-266.3M
Q1 24
$90.3M
$-294.0M
Total Assets
IRTC
IRTC
MSGS
MSGS
Q4 25
$1.0B
$1.5B
Q3 25
$995.2M
$1.5B
Q2 25
$964.0M
$1.5B
Q1 25
$926.1M
$1.5B
Q4 24
$931.4M
$1.4B
Q3 24
$909.7M
$1.4B
Q2 24
$919.2M
$1.3B
Q1 24
$909.8M
$1.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRTC
IRTC
MSGS
MSGS
Operating Cash FlowLast quarter
$26.2M
$32.4M
Free Cash FlowOCF − Capex
$14.5M
$31.6M
FCF MarginFCF / Revenue
6.9%
7.8%
Capex IntensityCapex / Revenue
5.6%
0.2%
Cash ConversionOCF / Net Profit
4.70×
3.94×
TTM Free Cash FlowTrailing 4 quarters
$34.5M
$-480.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRTC
IRTC
MSGS
MSGS
Q4 25
$26.2M
$32.4M
Q3 25
$34.9M
$-85.0M
Q2 25
$27.7M
$49.7M
Q1 25
$-7.9M
$6.3M
Q4 24
$19.2M
$61.8M
Q3 24
$24.3M
$-26.2M
Q2 24
$11.8M
$108.4M
Q1 24
$-52.0M
$4.0M
Free Cash Flow
IRTC
IRTC
MSGS
MSGS
Q4 25
$14.5M
$31.6M
Q3 25
$20.1M
$-85.3M
Q2 25
$17.3M
$49.4M
Q1 25
$-17.3M
$3.9M
Q4 24
$12.4M
$61.2M
Q3 24
$15.5M
$-26.5M
Q2 24
$3.4M
$108.0M
Q1 24
$-61.8M
$3.9M
FCF Margin
IRTC
IRTC
MSGS
MSGS
Q4 25
6.9%
7.8%
Q3 25
10.4%
-216.3%
Q2 25
9.3%
24.2%
Q1 25
-10.9%
0.9%
Q4 24
7.5%
17.1%
Q3 24
10.5%
-49.7%
Q2 24
2.3%
47.5%
Q1 24
-46.8%
0.9%
Capex Intensity
IRTC
IRTC
MSGS
MSGS
Q4 25
5.6%
0.2%
Q3 25
7.7%
0.9%
Q2 25
5.6%
0.2%
Q1 25
5.9%
0.6%
Q4 24
4.2%
0.1%
Q3 24
6.0%
0.7%
Q2 24
5.7%
0.2%
Q1 24
7.4%
0.0%
Cash Conversion
IRTC
IRTC
MSGS
MSGS
Q4 25
4.70×
3.94×
Q3 25
Q2 25
Q1 25
Q4 24
55.61×
Q3 24
Q2 24
4.25×
Q1 24
0.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRTC
IRTC

Commercial Payors$111.7M53%
Centers For Medicare And Medicaid$49.2M24%
Healthcare Institutions$34.3M16%
Non Contracted Third Party Payors$13.7M7%

MSGS
MSGS

Event Related$167.2M41%
Media Rights$122.3M30%
Sponsorship Signage And Suite Licenses$98.5M24%
League Distribution$15.4M4%

Related Comparisons